Factors Targeting MED12 to Drive Tumorigenesis?

F1000Research - United Kingdom
doi 10.12688/f1000research.14227.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

METTL3 Promotes mRNA Translation to Drive Tumorigenesis

Cancer Discovery
Oncology
2018English

Nuclear cGAS Blocks DNA Repair to Drive Tumorigenesis

Cancer Discovery
Oncology
2018English

Two MYC Homology Boxes Drive Tumorigenesis

Cancer Discovery
Oncology
2018English

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions That Cooperate to Drive Tumorigenesis

Molecular Cell
Cell BiologyMolecular Biology
2018English

MYC Interacts With the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis Through ATF4 and C-Myc

Cancer Discovery
Oncology
2018English

TEAD4 Promotes Colorectal Tumorigenesis via Transcriptionally Targeting YAP1

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

Apc Inactivation, but Not Obesity, Synergizes With Pten Deficiency to Drive Intestinal Stem Cell-Derived Tumorigenesis

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Factors Affecting the Loss of MED12-mutated Leiomyoma Cells During in Vitro Growth

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy